Home/Filings/4/0000950170-23-071875
4//SEC Filing

Kohli Prashant 4

Accession 0000950170-23-071875

CIK 0001444192other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:05 PM ET

Size

5.1 KB

Accession

0000950170-23-071875

Insider Transaction Report

Form 4
Period: 2023-12-19
Kohli Prashant
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2023-12-19+41,66841,668 total
    Exercise: $2.13Exp: 2033-12-19Class A Common Shares (41,668 underlying)
Footnotes (1)
  • [F1]Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant.

Documents

1 file

Issuer

Acasti Pharma Inc.

CIK 0001444192

Entity typeother

Related Parties

1
  • filerCIK 0001946739

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:05 PM ET
Size
5.1 KB